dihydrotestosterone has been researched along with testosterone undecanoate in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (37.93) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Coert, A; Hirschhäuser, C; Hopkinson, CR; Sturm, G | 1 |
| Coert, A; de Visser, J; Geelen, J; van der Vies, J | 1 |
| Björntorp, P; Krotkiewski, M; Mårin, P | 1 |
| Butler, GE; Hendry, M; Kelnar, CJ; Sellar, RE; Walker, RF; Wu, FC | 1 |
| Gooren, LJ | 3 |
| Bancroft, J; Davidson, DW; O'Carroll, R | 1 |
| Drop, SL; Sabbe-Claus, L; Visser, HK | 1 |
| Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M | 1 |
| O'Carroll, RE | 1 |
| Bancroft, J; Davidson, DW; Skakkebaek, NE; Warner, P | 1 |
| Bancroft, J; Davidson, DW; Nicol, K; Wu, FC | 1 |
| Deslypere, JP; Giagulli, VA; Giorgino, R; Verdonck, L; Vermeulen, A | 1 |
| Jockenhövel, F; Reinhardt, W; Reinwein, D; Vogel, E | 1 |
| Abshagen, K; Behre, HM; Büchter, D; Nieschlag, E; Simoni, M; Von Eckardstein, S | 1 |
| Karpischenko, AI; Mazurov, VI; Mikhailichenko, VV; Pechersky, AV; Semiglazov, VF; Udintsev, AV | 1 |
| Bullmann, C; Jockenhövel, F; Krone, W; Minnemann, T; Reiners, C; Schubert, M | 1 |
| Charman, WN; Edwards, GA; Faassen, WA; Houwing, N; Lass, H; Porter, CJ; Shackleford, DM | 1 |
| Bagchus, WM; Houwing, NS; Maris, F; Schnabel, PG | 1 |
| Cai, RF; Cue, YG; Di, FS; Jia, Y; Ma, DZ; Tong, JS; Wang, XD; Wang, XH | 1 |
| Saad, F; Yassin, AA | 1 |
| Altieri, P; Armillotta, F; Costantino, A; Ghi, T; Kalhorn, T; Meriggiola, MC; Pelusi, C; Pelusi, G; Perrone, AM; Saad, F | 1 |
| Gooren, LJ; Haide, A; Saad, F; Yassin, A | 1 |
| Delbeke, FT; Van Eenoo, P; Van Renterghem, P | 1 |
| Amory, JK; Christenson, P; Dudley, RE; Hull, L; Leung, A; Roth, MY; Swerdloff, R; Wang, C | 1 |
| Conway, A; Curtis, D; Goebel, C; Handelsman, DJ; Jayadev, V; Lim, S; Savkovic, S; Turner, L | 1 |
| Bracken, K; Conway, AJ; Desai, R; Grossmann, M; Handelsman, DJ; Inder, WJ; Jesudason, D; Ly, LP; Shankara-Narayana, N; Stuckey, BGA; Wittert, GA; Yeap, BB | 1 |
| An, J; Kong, H | 1 |
12 trial(s) available for dihydrotestosterone and testosterone undecanoate
| Article | Year |
|---|---|
Testosterone undecanoate: a new orally active androgen.
Topics: 17-Ketosteroids; Administration, Oral; Adult; Androgens; Clinical Trials as Topic; Dihydrotestosterone; Fatty Acids; Humans; Hypogonadism; Male; Placebos; Stimulation, Chemical; Testosterone | 1975 |
Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
Topics: Adult; Clinical Trials as Topic; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 1981 |
The behavioural effects of testosterone undecanoate in adult men with Klinefelter's syndrome: a controlled study.
Topics: Adult; Dihydrotestosterone; Double-Blind Method; Humans; Klinefelter Syndrome; Libido; Male; Middle Aged; Sexual Behavior; Testosterone | 1982 |
Effects of various modes of androgen substitution therapy on erythropoiesis.
Topics: Adult; Dihydrotestosterone; Drug Implants; Erythropoiesis; Ferritins; Hematocrit; Hemoglobins; Humans; Hypogonadism; Iron; Male; Mesterolone; Regression Analysis; Testosterone; Testosterone Congeners | 1997 |
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
Topics: Adult; Analysis of Variance; Body Weight; Dihydrotestosterone; Ejaculation; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
Topics: Adult; Aged; Androgens; Bone Density; Dihydrotestosterone; Double-Blind Method; Drug Implants; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Mesterolone; Middle Aged; Osteoporosis; Prospective Studies; Steroids; Testosterone | 2003 |
Pharmacokinetic study in women of three different doses of a new formulation of oral testosterone undecanoate, Andriol Testocaps.
Topics: Administration, Oral; Aged; Area Under Curve; Biological Availability; Capsules; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Liver; Middle Aged; Testosterone; Time Factors | 2003 |
Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 2007 |
Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.
Topics: Adolescent; Adult; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Estradiol; Female; Follicle Stimulating Hormone; Humans; Letrozole; Luteinizing Hormone; Male; Middle Aged; Nitriles; Sex Hormone-Binding Globulin; Testosterone; Transsexualism; Triazoles; Young Adult | 2008 |
Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
Topics: Aging; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Testosterone | 2008 |
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.
Topics: Administration, Oral; Adolescent; Adult; Cholestenone 5 alpha-Reductase; Cross-Over Studies; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Testosterone; Young Adult | 2011 |
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Follicle Stimulating Hormone; Follow-Up Studies; Genitalia, Male; Glucose Intolerance; Humans; Hypogonadism; Injections; Luteinizing Hormone; Male; Middle Aged; Quality of Life; Recovery of Function; Sexual Behavior; Testosterone; Withholding Treatment | 2022 |
17 other study(ies) available for dihydrotestosterone and testosterone undecanoate
| Article | Year |
|---|---|
The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.
Topics: Animals; Blood Proteins; Dihydrotestosterone; Fatty Acids; Intestinal Absorption; Intestine, Small; Liver; Lymph; Male; Protein Binding; Rats; Testosterone; Testosterone Congeners | 1975 |
Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Topics: Adipose Tissue; Biopsy; Body Composition; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Evaluation; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Muscles; Obesity; Testosterone | 1992 |
Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
Topics: Administration, Oral; Adolescent; Aging; Biological Availability; Body Height; Bone and Bones; Dihydrotestosterone; Estradiol; Growth; Humans; Luteinizing Hormone; Male; Puberty, Delayed; Saliva; Sex Hormone-Binding Globulin; Sexual Maturation; Testosterone; Time Factors | 1992 |
Androgen levels and sex functions in testosterone-treated hypogonadal men.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Dihydrotestosterone; Drug Combinations; Humans; Hypogonadism; Injections; Male; Methyltestosterone; Middle Aged; Sexual Behavior; Tamoxifen; Testosterone; Time Factors | 1987 |
Increasing circulating androgens with oral testosterone undecanoate in eugonadal men.
Topics: Absorption; Adult; Androgens; Dihydrotestosterone; Humans; Kinetics; Male; Middle Aged; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Testosterone | 1987 |
Exogenous androgens decrease the length of the luteal phase and increase the length of the follicular phase.
Topics: Adult; Androgens; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Luteal Phase; Luteinizing Hormone; Progesterone; Testosterone | 1985 |
Human male sexual functions do not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone.
Topics: Adult; Dihydrotestosterone; Estradiol; Humans; Male; Sexual Behavior; Tamoxifen; Testicular Diseases; Testolactone; Testosterone | 1985 |
The effect of puberty and short-term oral administration of testosterone undecanoate on GH tests and sex-steroid related plasma compounds in GH deficient patients.
Topics: Adolescent; Androstenedione; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Ethinyl Estradiol; Female; Growth Hormone; Humans; Male; Puberty; Sex Hormone-Binding Globulin; Testosterone | 1982 |
Which testosterone replacement therapy?
Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 1984 |
Plasma steroids and sex hormone binding globulin estimation.
Topics: Adult; Dihydrotestosterone; Humans; Male; Sex Hormone-Binding Globulin; Testosterone | 1983 |
Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Androstane-3,17-diol; Dihydrotestosterone; Humans; Male; Middle Aged; Splanchnic Circulation; Testosterone | 1993 |
Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume.
Topics: Adult; Aged; Aged, 80 and over; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Prospective Studies; Prostate; Testosterone; Testosterone Congeners; Time Factors | 2002 |
Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs.
Topics: Absorption; Administration, Oral; Animals; Biological Transport; Catheterization; Dihydrotestosterone; Dogs; Female; Lymph; Lymphatic System; Male; Testosterone | 2003 |
[Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
Topics: Animals; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dose-Response Relationship, Drug; Finasteride; Male; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testis; Testosterone | 2005 |
Population based evaluation of a multi-parametric steroid profiling on administered endogenous steroids in single low dose.
Topics: Administration, Oral; Adult; Androstenols; Dehydroepiandrosterone; Dihydrotestosterone; Doping in Sports; Humans; Male; Reference Values; ROC Curve; Testosterone; Urinalysis; Young Adult | 2010 |
Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Topics: Adolescent; Adult; Androgens; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Humans; Hypogonadism; Luteinizing Hormone; Male; Mass Spectrometry; Middle Aged; Testosterone; Transgender Persons; Transsexualism; Young Adult | 2018 |
Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats.
Topics: Animals; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Rats; Rats, Wistar; Reproducibility of Results; Testosterone; Testosterone Propionate | 2022 |